Protagonist Therapeutics PTGX Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's net debt?
- Protagonist Therapeutics (PTGX) reported net debt of -$183.94M in Q1 2026.
- How has Protagonist Therapeutics's net debt changed year-over-year?
- Protagonist Therapeutics's net debt decreased by 43.4% year-over-year, from -$128.29M to -$183.94M.
- What is the long-term trend for Protagonist Therapeutics's net debt?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's net debt has grown at a 1.2% compound annual growth rate (CAGR), from -$111.4M to -$118.07M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.